These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28740611)

  • 1. Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification.
    Takayama K; Rentier C; Asari T; Nakamura A; Saga Y; Shimada T; Nirasawa K; Sasaki E; Muguruma K; Taguchi A; Taniguchi A; Negishi Y; Hayashi Y
    ACS Med Chem Lett; 2017 Jul; 8(7):751-756. PubMed ID: 28740611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for the Effective Myostatin Inhibition of the Mouse Myostatin Prodomain-Derived Minimum Peptide.
    Asari T; Takayama K; Nakamura A; Shimada T; Taguchi A; Hayashi Y
    ACS Med Chem Lett; 2017 Jan; 8(1):113-117. PubMed ID: 28105285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-Terminal Acylation on the Activity of Myostatin Inhibitory Peptides.
    Takayama K; Nakamura A; Rentier C; Mino Y; Asari T; Saga Y; Taguchi A; Yakushiji F; Hayashi Y
    ChemMedChem; 2016 Apr; 11(8):845-9. PubMed ID: 26954624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of potent myostatin inhibitory cyclic peptides.
    Rentier C; Takayama K; Saitoh M; Nakamura A; Ikeyama H; Taguchi A; Taniguchi A; Hayashi Y
    Bioorg Med Chem; 2019 Apr; 27(7):1437-1443. PubMed ID: 30777663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medicinal Chemistry Focused on Mid-sized Peptides Derived from Biomolecules].
    Takayama K
    Yakugaku Zasshi; 2019; 139(11):1377-1384. PubMed ID: 31685733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic structure-activity relationship study on a follistatin-derived myostatin inhibitory peptide.
    Saitoh M; Takayama K; Roppongi Y; Shimada T; Taguchi A; Taniguchi A; Hayashi Y
    Bioorg Med Chem Lett; 2021 Aug; 46():128163. PubMed ID: 34087433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide Tool-Driven Functional Elucidation of Biomolecules Related to Endocrine System and Metabolism.
    Takayama K
    Chem Pharm Bull (Tokyo); 2022; 70(6):413-419. PubMed ID: 35650039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition.
    Takayama K; Noguchi Y; Aoki S; Takayama S; Yoshida M; Asari T; Yakushiji F; Nishimatsu S; Ohsawa Y; Itoh F; Negishi Y; Sunada Y; Hayashi Y
    J Med Chem; 2015 Feb; 58(3):1544-9. PubMed ID: 25569186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice.
    Takayama K; Asari T; Saitoh M; Nirasawa K; Sasaki E; Roppongi Y; Nakamura A; Saga Y; Shimada T; Ikeyama H; Taguchi A; Taniguchi A; Negishi Y; Hayashi Y
    ACS Med Chem Lett; 2019 Jun; 10(6):985-990. PubMed ID: 31223459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for the binding mode of the 23-mer inhibitory peptide to myostatin.
    Asari T; Ikeyama H; Taguchi A; Taniguchi A; Hayashi Y; Takayama K
    Bioorg Med Chem; 2021 Jun; 40():116181. PubMed ID: 33957441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor Design Strategy for Myostatin: Dynamics and Interaction Networks Define the Affinity and Release Mechanisms of the Inhibited Complexes.
    Nagy-Fazekas D; Fazekas Z; Taricska N; Stráner P; Karancsiné Menyhárd D; Perczel A
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Myostatin Inhibitory d-Peptides to Enhance the Potency, Increasing Skeletal Muscle Mass in Mice.
    Takayama K; Hitachi K; Okamoto H; Saitoh M; Odagiri M; Ohfusa R; Shimada T; Taguchi A; Taniguchi A; Tsuchida K; Hayashi Y
    ACS Med Chem Lett; 2022 Mar; 13(3):492-498. PubMed ID: 35300091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the minimum region of flatfish myostatin propeptide (Pep45-65) for myostatin inhibition and its potential to enhance muscle growth and performance in animals.
    Kim JH; Kim JH; Sutikno LA; Lee SB; Jin DH; Hong YK; Kim YS; Jin HJ
    PLoS One; 2019; 14(4):e0215298. PubMed ID: 30998775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin inhibitory region of fish (Paralichthys olivaceus) myostatin-1 propeptide.
    Lee SB; Kim JH; Jin DH; Jin HJ; Kim YS
    Comp Biochem Physiol B Biochem Mol Biol; 2016; 194-195():65-70. PubMed ID: 26827850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic Stability of Myostatin Inhibitory 16-mer Peptides.
    Takayama K; Odagiri M; Taguchi A; Taniguchi A; Hayashi Y
    Chem Pharm Bull (Tokyo); 2020; 68(6):512-515. PubMed ID: 32475853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.
    Glass DB; Trewhella J; Mitchell RD; Walsh DA
    Protein Sci; 1995 Mar; 4(3):405-15. PubMed ID: 7795524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of myostatin gene structure, expression and function in zebrafish.
    Xu C; Wu G; Zohar Y; Du SJ
    J Exp Biol; 2003 Nov; 206(Pt 22):4067-79. PubMed ID: 14555747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.